What's more, Xue and colleagues reported that IL-1β combined with IL-4, in the absence of TGF-β, induced a non-canonical Th9 subset that was less exhausted and showed superior anti-tumor effects to classic Th9 cells induced by TGF-β and IL-4. This evidence concerns the gene IL4 and neoplasm.